// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The relationship between two different measures of osteoarthritis bone pathology, bone marrow lesions and 3D bone shape: data from the osteoarthritis initiative

B. Dube - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Associations between radiographic hip OA assessed using Kellgren–Lawrence grading and hip shape characterised using statistical shape modelling in a British birth cohort

I. Faliszewski - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The relationship between accurate 3D measurements of cartilage thickness and radiographic joint space width: data from the osteoarthritis initiative

M.A. Bowes - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Repeatability and discrimination validity of cartilage imaging biomarkers for experimental medicine studies of knee osteoarthritis

J.W. MacKay - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Methadone hydrochloride

Longitudinal survey for high density mineralised protrusions identified by 3D dess MRI in patients of the osteoarthritis initiative

N.P. Thomas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The reproducibility of T2 relaxation time measurement of knee cartilage in women aged over 50

C. Hartley - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

N/A

Screening for selective aggrecanase substrates to detect early proteolytic events in cartilage degradation

M.M. Fowkes - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

TIMP-3 secretion inducer

Fast-field cycling magnetic resonance imaging – developing a new biomarker for early osteoarthritis of the knee

I.A. Rankin - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

What Rare Diseases Can Tell Us About OA

J.A. Gallagher - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

From OA Risk Genes to Underlying Disease Mechanisms

J. Loughlin - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Potential for Dietary Factors to Prevent or Treat OA

I.M. Clark - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Study TPX-100-5: Significant reduction in femoral bone shape change 12 months after IA TPX-100 correlates with tibiofemoral cartilage stabilization

D. McGuire - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

TPX100

The tyrosine kinase receptor EPHA2 is a drug target for osteoarthritis

M. N. Ferrao Blanco - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

ILS-969

In vivo silac labelling identifies newly synthesised proteins early after destabilisation of the medial meniscus in mice

Y. Ariosa-Morejon - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Trypsin

Experiences of persons with knee osteoarthritis using a wearable-enabled intervention involving counselling by a physiotherapist to support physical activity: a secondary analysis using an ethics lens

J. Leese - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Synergistic effects of hip and knee osteoarthritis and comorbidities among older adults: analysis of the oxford pain, activity and lifestyle cohort study

P.J. Nicolson - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Expression of growth and differentiation factor 5 during joint repair and osteoarthritis

K. Kania - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Intrameniscal signal alterations strongly predict destabilizing meniscal tears and accelerated knee osteoarthritis: data from the osteoarthritis initiative

J.B. Driban - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Methadone hydrochloride

A novel structural status assessment of oa is strongly associated with all patient important outcomes - an mri study of 9,433 knees from the osteoarthritis initiative

M.A. Bowes - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

A comparison between high density mineralised protrusions identified in the knees of cadavers and in patients of the osteoarthritis initiative

N.P. Thomas - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved